CAS
GOSS icon

CTC Alternative Strategies’s Gossamer Bio GOSS Stock Holding History

CTC Alternative Strategies’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,600
Closed -$18.3K – 163
2025
Q1 		$18.3K Buy
+16,600
New +$19.2K 0.02% 88
2024
Q2 		– Sell
-49,500
Closed -$58.4K – 219
2024
Q1 		$58.4K Buy
+49,500
New +$54.5K 0.04% 104

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CTC Alternative Strategies's GOSS Position: Q2 2025 in Review

CTC Alternative Strategies sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 16,600 shares — an estimated $18.3K sold.

CTC Alternative Strategies first reported a position in GOSS in Q1 2024 and held it in 2 quarters. The position peaked at $58.4K in Q1 2024. 123 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

  • CTC Alternative Strategies reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
  • CTC Alternative Strategies sold 16,600 Gossamer Bio shares in Q2 2025, an estimated $18.3K.
  • CTC Alternative Strategies first reported a position in Gossamer Bio in Q1 2024 and held it in 2 quarters.
  • CTC Alternative Strategies's Gossamer Bio position peaked at $58.4K in Q1 2024.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on CTC Alternative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.